{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:08:55Z","timestamp":1792267735818,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>While treatments exist for the acute phase of stroke, there are limited options for patients with chronic infarcts and long-term disability. Allogenic mesenchymal stem cells (alloMSCs) show promise for the treatment of stroke soon after ischemic injury. There is, however, no information on the use of autologous MSCs (autoMSCs), delivered intracerebrally in rats with a chronic infarct. In this study, rats underwent middle cerebral artery occlusion (MCAO) to induce stroke followed by bone marrow aspiration and MSC expansion in a closed bioreactor. Four weeks later, brain MRI was obtained and autoMSCs (1 \u00d7 10<jats:sup>6<\/jats:sup>, 2.5 \u00d7 10<jats:sup>6<\/jats:sup> or 5 \u00d7 10<jats:sup>6<\/jats:sup>; <jats:italic>n<\/jats:italic> = 6 each) were stereotactically injected into the peri-infarct and compared to controls (MCAO only; MCAO + PBS; <jats:italic>n<\/jats:italic> = 6\u20139). Behavior was assessed using the modified neurological severity score (mNSS). For comparison, an additional cohort of MCAO rats were implanted with 2.5 \u00d7 10<jats:sup>6<\/jats:sup> alloMSCs generated from a healthy rat. All doses of autoMSCs produced significant improvement (54\u201370%) in sensorimotor function 60 days later. In contrast, alloMSCs improved only 31.7%, similar to that in PBS controls 30%. Quantum dot\u2013labeled auto\/alloMSCs were found exclusively at the implantation site throughout the post-transplantation period with no tumor formation on MRI or Ki67 staining of engrafted MSCs. Small differences in stroke volume and no differences in corpus callosum width were observed after MSC treatment. Stroke-induced glial reactivity in the peri-infarct was long-lasting and unabated by auto\/alloMSC transplantation. These studies suggest that intracerebral transplantation of autoMSCs as compared to alloMSCs may be a promising treatment in chronic stroke.<\/jats:p>","DOI":"10.1007\/s12975-023-01208-7","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T06:01:46Z","timestamp":1698904906000},"page":"248-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intracerebral Transplantation of Autologous Mesenchymal Stem Cells Improves Functional Recovery in a Rat Model of Chronic Ischemic Stroke"],"prefix":"10.1007","volume":"16","author":[{"given":"Max I.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Spagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rosenwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Iacovitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"issue":"1","key":"1208_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","volume":"17","author":"VL Feigin","year":"2022","unstructured":"Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17(1):18\u201329. https:\/\/doi.org\/10.1177\/17474930211065917.","journal-title":"Int J Stroke."},{"key":"1208_CR2","doi-asserted-by":"publisher","first-page":"l6983","DOI":"10.1136\/bmj.l6983","volume":"368","author":"MS Phipps","year":"2020","unstructured":"Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ. 2020;368:l6983. https:\/\/doi.org\/10.1136\/bmj.l6983. Epub 20200213.","journal-title":"BMJ."},{"issue":"24","key":"1208_CR3","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological D, Stroke rt PASSG","year":"1995","unstructured":"National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581\u20137. https:\/\/doi.org\/10.1056\/NEJM199512143332401.","journal-title":"N Engl J Med."},{"issue":"2","key":"1208_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/1747493015620805","volume":"11","author":"H Amiri","year":"2016","unstructured":"Amiri H, Bluhmki E, Bendszus M, Eschenfelder CC, Donnan GA, Leys D, et al. European Cooperative Acute Stroke Study-4: extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND. Int J Stroke. 2016;11(2):260\u20137. https:\/\/doi.org\/10.1177\/1747493015620805.","journal-title":"Int J Stroke."},{"issue":"1","key":"1208_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","volume":"5","author":"BCV Campbell","year":"2019","unstructured":"Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5(1):70. https:\/\/doi.org\/10.1038\/s41572-019-0118-8. Epub 20191010.","journal-title":"Nat Rev Dis Primers."},{"issue":"4","key":"1208_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1474-4422(08)70044-9","volume":"7","author":"SM Davis","year":"2008","unstructured":"Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7(4):299\u2013309. https:\/\/doi.org\/10.1016\/S1474-4422(08)70044-9. Epub 20080228.","journal-title":"Lancet Neurol."},{"issue":"19","key":"1208_CR7","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJMoa1813046","volume":"380","author":"H Ma","year":"2019","unstructured":"Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019;380(19):1795\u2013803. https:\/\/doi.org\/10.1056\/NEJMoa1813046.","journal-title":"N Engl J Med."},{"issue":"1","key":"1208_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1747-4949.2011.00730.x","volume":"7","author":"H Ma","year":"2012","unstructured":"Ma H, Parsons MW, Christensen S, Campbell BC, Churilov L, Connelly A, et al. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke. 2012;7(1):74\u201380. https:\/\/doi.org\/10.1111\/j.1747-4949.2011.00730.x.","journal-title":"Int J Stroke."},{"issue":"8","key":"1208_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJMoa1713973","volume":"378","author":"GW Albers","year":"2018","unstructured":"Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1713973. Epub 20180124. PubMed PMID: 29364767; PubMed Central PMCID: PMCPMC6590673.","journal-title":"N Engl J Med."},{"issue":"10029","key":"1208_CR10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723\u201331. https:\/\/doi.org\/10.1016\/S0140-6736(16)00163-X. Epub 20160218.","journal-title":"Lancet"},{"issue":"1","key":"1208_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"RG Nogueira","year":"2018","unstructured":"Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1706442. Epub 20171111.","journal-title":"N Engl J Med."},{"issue":"5","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1161\/STROKEAHA.116.013165","volume":"47","author":"NH Chia","year":"2016","unstructured":"Chia NH, Leyden JM, Newbury J, Jannes J, Kleinig TJ. Determining the number of ischemic strokes potentially eligible for endovascular thrombectomy: a population-based study. Stroke. 2016;47(5):1377\u201380. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013165. Epub 20160317.","journal-title":"Stroke"},{"issue":"9","key":"1208_CR13","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1161\/01.STR.0000180861.54180.FF","volume":"36","author":"PW Duncan","year":"2005","unstructured":"Duncan PW, Zorowitz R, Bates B, Choi JY, Glasberg JJ, Graham GD, et al. Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke. 2005;36(9):e100\u201343. https:\/\/doi.org\/10.1161\/01.STR.0000180861.54180.FF.","journal-title":"Stroke"},{"issue":"2","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/STROKEAHA.113.003379","volume":"45","author":"SI Savitz","year":"2014","unstructured":"Savitz SI, Cramer SC, Wechsler L, Consortium S. Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke. 2014;45(2):634\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.113.003379. Epub 20131224. PubMed PMID: 24368562; PubMed Central PMCID: PMCPMC5823253.","journal-title":"Stroke"},{"issue":"7","key":"1208_CR15","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","volume":"47","author":"GK Steinberg","year":"2016","unstructured":"Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB, et al. Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study. Stroke. 2016;47(7):1817\u201324. https:\/\/doi.org\/10.1161\/STROKEAHA.116.012995. Epub 20160602. PubMed PMID: 27256670; PubMed Central PMCID: PMCPMC5828512.","journal-title":"Stroke"},{"issue":"11","key":"1208_CR16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.5966\/sctm.2013-0178","volume":"3","author":"S Banerjee","year":"2014","unstructured":"Banerjee S, Bentley P, Hamady M, Marley S, Davis J, Shlebak A, et al. Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke. Stem Cells Transl Med. 2014;3(11):1322\u201330. https:\/\/doi.org\/10.5966\/sctm.2013-0178. Epub 20140808. PubMed PMID: 25107583; PubMed Central PMCID: PMCPMC4214837.","journal-title":"Stem Cells Transl Med."},{"issue":"6","key":"1208_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","volume":"57","author":"OY Bang","year":"2005","unstructured":"Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57(6):874\u201382. https:\/\/doi.org\/10.1002\/ana.20501.","journal-title":"Ann Neurol."},{"issue":"4","key":"1208_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"1208_CR19","doi-asserted-by":"publisher","first-page":"2602871","DOI":"10.1155\/2021\/2602871","volume":"2021","author":"P Gong","year":"2021","unstructured":"Gong P, Zhang W, He Y, Wang J, Li S, Chen S, et al. Classification and characteristics of mesenchymal stem cells and its potential therapeutic mechanisms and applications against ischemic stroke. Stem Cells Int. 2021;2021:2602871. https:\/\/doi.org\/10.1155\/2021\/2602871. Epub 20211109. PubMed PMID: 34795764; PubMed Central PMCID: PMCPMC8595011.","journal-title":"Stem Cells Int."},{"issue":"3","key":"1208_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","volume":"4","author":"JM Karp","year":"2009","unstructured":"Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4(3):206\u201316. https:\/\/doi.org\/10.1016\/j.stem.2009.02.001.","journal-title":"Cell Stem Cell."},{"key":"1208_CR21","doi-asserted-by":"publisher","first-page":"119942","DOI":"10.1016\/j.biomaterials.2020.119942","volume":"243","author":"HY Kim","year":"2020","unstructured":"Kim HY, Kim TJ, Kang L, Kim YJ, Kang MK, Kim J, et al. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke. Biomaterials. 2020;243:119942. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119942. Epub 20200306.","journal-title":"Biomaterials"},{"issue":"3","key":"1208_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/dgd.12049","volume":"55","author":"M Konno","year":"2013","unstructured":"Konno M, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Nishikawa S, et al. Adipose-derived mesenchymal stem cells and regenerative medicine. Dev Growth Differ. 2013;55(3):309\u201318. https:\/\/doi.org\/10.1111\/dgd.12049. Epub 20130303.","journal-title":"Dev Growth Differ."},{"issue":"12","key":"1208_CR23","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","volume":"45","author":"K Prasad","year":"2014","unstructured":"Prasad K, Sharma A, Garg A, Mohanty S, Bhatnagar S, Johri S, et al. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke. 2014;45(12):3618\u201324. https:\/\/doi.org\/10.1161\/STROKEAHA.114.007028. Epub 20141106.","journal-title":"Stroke"},{"issue":"10","key":"1208_CR24","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1111\/trf.14805","volume":"58","author":"AL Russell","year":"2018","unstructured":"Russell AL, Lefavor RC, Zubair AC. Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications. Transfusion. 2018;58(10):2374\u201382. https:\/\/doi.org\/10.1111\/trf.14805. Epub 20180910.","journal-title":"Transfusion"},{"issue":"2","key":"1208_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1006\/exnr.2000.7389","volume":"164","author":"J Sanchez-Ramos","year":"2000","unstructured":"Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164(2):247\u201356. https:\/\/doi.org\/10.1006\/exnr.2000.7389.","journal-title":"Exp Neurol."},{"issue":"10","key":"1208_CR26","doi-asserted-by":"publisher","first-page":"e26577","DOI":"10.1371\/journal.pone.0026577","volume":"6","author":"M Sasaki","year":"2011","unstructured":"Sasaki M, Honmou O, Radtke C, Kocsis JD. Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells. PLoS One. 2011;6(10):e26577. https:\/\/doi.org\/10.1371\/journal.pone.0026577. Epub 20111024 PubMed PMID: 22039510; PubMed Central PMCID: PMCPMC3200343.","journal-title":"PLoS One."},{"issue":"1","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ana.22458","volume":"70","author":"SI Savitz","year":"2011","unstructured":"Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, Alderman S, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011;70(1):59\u201369. https:\/\/doi.org\/10.1002\/ana.22458.","journal-title":"Ann Neurol."},{"key":"1208_CR28","doi-asserted-by":"publisher","unstructured":"Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Kim AS, Johnson JN, et al. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1\/2a study. J Neurosurg. 2018:1\u201311. Epub 20181123. https:\/\/doi.org\/10.3171\/2018.5.JNS173147.","DOI":"10.3171\/2018.5.JNS173147"},{"issue":"3","key":"1208_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.nbd.2012.03.002","volume":"46","author":"L Wei","year":"2012","unstructured":"Wei L, Fraser JL, Lu ZY, Hu X, Yu SP. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis. 2012;46(3):635\u201345. https:\/\/doi.org\/10.1016\/j.nbd.2012.03.002. Epub 20120309. PubMed PMID: 22426403; PubMed Central PMCID: PMCPMC3353023.","journal-title":"Neurobiol Dis."},{"key":"1208_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pneurobio.2017.03.003","volume":"157","author":"L Wei","year":"2017","unstructured":"Wei L, Wei ZZ, Jiang MQ, Mohamad O, Yu SP. Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke. Prog Neurobiol. 2017;157:49\u201378. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.03.003. Epub 20170318. PubMed PMID: 28322920; PubMed Central PMCID: PMCPMC5603356.","journal-title":"Prog Neurobiol."},{"issue":"3","key":"1208_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/hh0302.104460","volume":"90","author":"ZG Zhang","year":"2002","unstructured":"Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res. 2002;90(3):284\u20138. https:\/\/doi.org\/10.1161\/hh0302.104460.","journal-title":"Circ Res."},{"key":"1208_CR32","doi-asserted-by":"publisher","unstructured":"Namioka T, Namioka A, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, et al. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction. J Neurosurg. 2018:1\u20138. Epub 20181001. https:\/\/doi.org\/10.3171\/2018.5.JNS18140.","DOI":"10.3171\/2018.5.JNS18140"},{"key":"1208_CR33","doi-asserted-by":"publisher","first-page":"535902","DOI":"10.3389\/fmed.2020.535902","volume":"7","author":"Y Ogawa","year":"2020","unstructured":"Ogawa Y, Okinaka Y, Takeuchi Y, Saino O, Kikuchi-Taura A, Taguchi A. Intravenous bone marrow mononuclear cells transplantation improves the effect of training in chronic stroke mice. Front Med (Lausanne). 2020;7:535902. https:\/\/doi.org\/10.3389\/fmed.2020.535902. epub 20201126. PubMed PMID: 33324656; PubMed Central PMCID: PMCPMC7726263.","journal-title":"Front Med (Lausanne)."},{"issue":"8","key":"1208_CR34","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105932","volume":"30","author":"Y Ogawa","year":"2021","unstructured":"Ogawa Y, Saino O, Okinaka Y, Kikuchi-Taura A, Takeuchi Y, Taguchi A. Bone marrow mononuclear cells transplantation and training increased transplantation of energy source transporters in chronic stroke. J Stroke Cerebrovasc Dis. 2021;30(8):105932. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.105932. Epub 20210618.","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"1","key":"1208_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/jcbfm.2009.198","volume":"30","author":"M Brenneman","year":"2010","unstructured":"Brenneman M, Sharma S, Harting M, Strong R, Cox CS Jr, Aronowski J, et al. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab. 2010;30(1):140\u20139. https:\/\/doi.org\/10.1038\/jcbfm.2009.198. Epub 20090923. PubMed PMID: 19773802; PubMed Central PMCID: PMCPMC2893568.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"12","key":"1208_CR36","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1172\/JCI20935","volume":"113","author":"M Dezawa","year":"2004","unstructured":"Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest. 2004;113(12):1701\u201310. https:\/\/doi.org\/10.1172\/JCI20935. PubMed PMID: 15199405; PubMed Central PMCID: PMCPMC420509.","journal-title":"J Clin Invest."},{"issue":"3","key":"1208_CR37","doi-asserted-by":"publisher","first-page":"e60049","DOI":"10.1371\/journal.pone.0060049","volume":"8","author":"GV Goldmacher","year":"2013","unstructured":"Goldmacher GV, Nasser R, Lee DY, Yigit S, Rosenwasser R, Iacovitti L. Tracking transplanted bone marrow stem cells and their effects in the rat MCAO stroke model. PLoS One. 2013;8(3):e60049. https:\/\/doi.org\/10.1371\/journal.pone.0060049. Epub 20130329. PubMed PMID: 23555879; PubMed Central PMCID: PMCPMC3612030.","journal-title":"PLoS One."},{"issue":"3","key":"1208_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1440-1789.2011.01260.x","volume":"32","author":"M Kawabori","year":"2012","unstructured":"Kawabori M, Kuroda S, Sugiyama T, Ito M, Shichinohe H, Houkin K, et al. Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: an optical imaging study. Neuropathology. 2012;32(3):217\u201326. https:\/\/doi.org\/10.1111\/j.1440-1789.2011.01260.x. Epub 20111018.","journal-title":"Neuropathology"},{"issue":"14","key":"1208_CR39","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000278","volume":"82","author":"Q Vu","year":"2014","unstructured":"Vu Q, Xie K, Eckert M, Zhao W, Cramer SC. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology. 2014;82(14):1277\u201386. https:\/\/doi.org\/10.1212\/WNL.0000000000000278. Epub 20140307. PubMed PMID: 24610327; PubMed Central PMCID: PMCPMC4001201.","journal-title":"Neurology"},{"issue":"6","key":"1208_CR40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jnr.22614","volume":"89","author":"B Yang","year":"2011","unstructured":"Yang B, Strong R, Sharma S, Brenneman M, Mallikarjunarao K, Xi X, et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res. 2011;89(6):833\u20139. https:\/\/doi.org\/10.1002\/jnr.22614. Epub 20110315. PubMed PMID: 21412816; PubMed Central PMCID: PMCPMC3412881.","journal-title":"J Neurosci Res."},{"issue":"9","key":"1208_CR41","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3727\/096368910X503415","volume":"19","author":"M Yang","year":"2010","unstructured":"Yang M, Wei X, Li J, Heine LA, Rosenwasser R, Iacovitti L. Changes in host blood factors and brain glia accompanying the functional recovery after systemic administration of bone marrow stem cells in ischemic stroke rats. Cell Transplant. 2010;19(9):1073\u201384. https:\/\/doi.org\/10.3727\/096368910X503415. Epub 20100421.","journal-title":"Cell Transplant."},{"key":"1208_CR42","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.nicl.2019.101947","volume":"24","author":"S Bayrak","year":"2019","unstructured":"Bayrak S, Khalil AA, Villringer K, Fiebach JB, Villringer A, Margulies DS, et al. The impact of ischemic stroke on connectivity gradients. Neuroimage Clin. 2019;24:101947. https:\/\/doi.org\/10.1016\/j.nicl.2019.101947. Epub 20190719. PubMed PMID: 31376644; PubMed Central PMCID: PMCPMC6676042.","journal-title":"Neuroimage Clin."},{"issue":"2","key":"1208_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/STROKEAHA.114.007105","volume":"46","author":"T Diamandis","year":"2015","unstructured":"Diamandis T, Borlongan CV. One, two, three steps toward cell therapy for stroke. Stroke. 2015;46(2):588\u201391. https:\/\/doi.org\/10.1161\/STROKEAHA.114.007105. Epub 20141211. PubMed PMID: 25503552; PubMed Central PMCID: PMCPMC4354885.","journal-title":"Stroke"},{"issue":"7","key":"1208_CR44","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.clinph.2019.04.004","volume":"130","author":"AG Guggisberg","year":"2019","unstructured":"Guggisberg AG, Koch PJ, Hummel FC, Buetefisch CM. Brain networks and their relevance for stroke rehabilitation. Clin Neurophysiol. 2019;130(7):1098\u2013124. https:\/\/doi.org\/10.1016\/j.clinph.2019.04.004. Epub 20190415. PubMed PMID: 31082786; PubMed Central PMCID: PMCPMC6603430.","journal-title":"Clin Neurophysiol."},{"issue":"1","key":"1208_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","volume":"103","author":"D Kondziolka","year":"2005","unstructured":"Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg. 2005;103(1):38\u201345. https:\/\/doi.org\/10.3171\/jns.2005.103.1.0038.","journal-title":"J Neurosurg."},{"issue":"5","key":"1208_CR46","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000147636","volume":"86","author":"LD Lunsford","year":"2008","unstructured":"Lunsford LD, Niranjan A, Khan AA, Kondziolka D. Establishing a benchmark for complications using frame-based stereotactic surgery. Stereotact Funct Neurosurg. 2008;86(5):278\u201387. https:\/\/doi.org\/10.1159\/000147636. Epub 20080726.","journal-title":"Stereotact Funct Neurosurg."},{"issue":"10","key":"1208_CR47","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1161\/STROKEAHA.118.021319","volume":"49","author":"J Puig","year":"2018","unstructured":"Puig J, Blasco G, Alberich-Bayarri A, Schlaug G, Deco G, Biarnes C, et al. Resting-state functional connectivity magnetic resonance imaging and outcome after acute stroke. Stroke. 2018;49(10):2353\u201360. https:\/\/doi.org\/10.1161\/STROKEAHA.118.021319. PubMed PMID: 30355087; PubMed Central PMCID: PMCPMC6645916.","journal-title":"Stroke"},{"issue":"1","key":"1208_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/icb.2012.67","volume":"91","author":"MD Griffin","year":"2013","unstructured":"Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol Cell Biol. 2013;91(1):40\u201351. https:\/\/doi.org\/10.1038\/icb.2012.67. Epub 20121204.","journal-title":"Immunol Cell Biol."},{"issue":"6","key":"1208_CR49","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","volume":"108","author":"AJ Nauta","year":"2006","unstructured":"Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood. 2006;108(6):2114\u201320. https:\/\/doi.org\/10.1182\/blood-2005-11-011650. Epub 20060511. PubMed PMID: 16690970; PubMed Central PMCID: PMCPMC1895546.","journal-title":"Blood"},{"key":"1208_CR50","doi-asserted-by":"publisher","first-page":"963689721103446","DOI":"10.1177\/09636897211034464","volume":"30","author":"FP Benavides","year":"2021","unstructured":"Benavides FP, Pinto GBA, Heckler MCT, Hurtado DMR, Teixeira LR, Monobe MMS, et al. Intrathecal transplantation of autologous and allogeneic bone marrow-derived mesenchymal stem cells in dogs. Cell Transplant. 2021;30:9636897211034464. https:\/\/doi.org\/10.1177\/09636897211034464. PubMed PMID: 34427495; PubMed Central PMCID: PMCPMC8388229.","journal-title":"Cell Transplant."},{"issue":"2","key":"1208_CR51","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/STROKEAHA.108.526863","volume":"40","author":"Stem Cell Therapies as an Emerging Paradigm in Stroke P","year":"2009","unstructured":"Stem Cell Therapies as an Emerging Paradigm in Stroke P. Stem cell therapies as an emerging paradigm in stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40(2):510\u20135. https:\/\/doi.org\/10.1161\/STROKEAHA.108.526863. Epub 20081218.","journal-title":"Stroke"},{"key":"1208_CR52","doi-asserted-by":"publisher","unstructured":"Takemura M, Sasaki M, Kataoka-Sasaki Y, Kiyose R, Nagahama H, Oka S, et al. Repeated intravenous infusion of mesenchymal stem cells for enhanced functional recovery in a rat model of chronic cerebral ischemia. J Neurosurg. 2021:1\u201310. Epub 20211203. https:\/\/doi.org\/10.3171\/2021.8.JNS21687.","DOI":"10.3171\/2021.8.JNS21687"},{"issue":"3","key":"1208_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/glia.20126","volume":"49","author":"Y Li","year":"2005","unstructured":"Li Y, Chen J, Zhang CL, Wang L, Lu D, Katakowski M, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia. 2005;49(3):407\u201317. https:\/\/doi.org\/10.1002\/glia.20126.","journal-title":"Glia"},{"issue":"5","key":"1208_CR54","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3324\/haematol.2018.206581","volume":"104","author":"K Xu","year":"2019","unstructured":"Xu K, Lee JY, Kaneko Y, Tuazon JP, Vale F, van Loveren H, et al. Human stem cells transplanted into the rat stroke brain migrate to the spleen via lymphatic and inflammation pathways. Haematologica. 2019;104(5):1062\u201373. https:\/\/doi.org\/10.3324\/haematol.2018.206581. Epub 20181204. PubMed PMID: 30514806; PubMed Central PMCID: PMCPMC6518907.","journal-title":"Haematologica"},{"key":"1208_CR55","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2013.06.001","volume":"58","author":"SW Yoo","year":"2013","unstructured":"Yoo SW, Chang DY, Lee HS, Kim GH, Park JS, Ryu BY, et al. Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-beta. Neurobiol Dis. 2013;58:249\u201357. https:\/\/doi.org\/10.1016\/j.nbd.2013.06.001. Epub 20130610.","journal-title":"Neurobiol Dis."},{"issue":"4","key":"1208_CR56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3858\/emm.2008.40.4.387","volume":"40","author":"SW Yoo","year":"2008","unstructured":"Yoo SW, Kim SS, Lee SY, Lee HS, Kim HS, Lee YD, et al. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp Mol Med. 2008;40(4):387\u201397. https:\/\/doi.org\/10.3858\/emm.2008.40.4.387. PubMed PMID: 18779651; PubMed Central PMCID: PMCPMC2679267.","journal-title":"Exp Mol Med."},{"issue":"2","key":"1208_CR57","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.expneurol.2008.02.027","volume":"211","author":"EM Andrews","year":"2008","unstructured":"Andrews EM, Tsai SY, Johnson SC, Farrer JR, Wagner JP, Kopen GC, et al. Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp Neurol. 2008;211(2):588\u201392. https:\/\/doi.org\/10.1016\/j.expneurol.2008.02.027. Epub 20080313. PubMed PMID: 18440506; PubMed Central PMCID: PMCPMC3932708.","journal-title":"Exp Neurol."},{"key":"1208_CR58","doi-asserted-by":"publisher","unstructured":"Bao X, Feng M, Wei J, Han Q, Zhao H, Li G, et al. Transplantation of Flk-1+ human bone marrow-derived mesenchymal stem cells promotes angiogenesis and neurogenesis after cerebral ischemia in rats. Eur J Neurosci. 34, 1. 2011:87\u201398. Epub 20110621. https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07733.x.","DOI":"10.1111\/j.1460-9568.2011.07733.x"},{"key":"1208_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.brainresbull.2019.04.006","volume":"149","author":"X Gao","year":"2019","unstructured":"Gao X, Wu D, Dou L, Zhang H, Huang L, Zeng J, et al. Protective effects of mesenchymal stem cells overexpressing extracellular regulating kinase 1\/2 against stroke in rats. Brain Res Bull. 2019;149:42\u201352. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.04.006. Epub 20190416.","journal-title":"Brain Res Bull."},{"key":"1208_CR60","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuroscience.2013.02.011","volume":"238","author":"JS Heo","year":"2013","unstructured":"Heo JS, Choi SM, Kim HO, Kim EH, You J, Park T, et al. Neural transdifferentiation of human bone marrow mesenchymal stem cells on hydrophobic polymer-modified surface and therapeutic effects in an animal model of ischemic stroke. Neuroscience. 2013;238:305\u201318. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.02.011. Epub 20130220.","journal-title":"Neuroscience"},{"key":"1208_CR61","doi-asserted-by":"publisher","first-page":"129145","DOI":"10.1155\/2014\/129145","volume":"2014","author":"CH Jeong","year":"2014","unstructured":"Jeong CH, Kim SM, Lim JY, Ryu CH, Jun JA, Jeun SS. Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model. Biomed Res Int. 2014;2014:129145. https:\/\/doi.org\/10.1155\/2014\/129145. Epub 20140205. PubMed PMID: 24672780; PubMed Central PMCID: PMCPMC3933216.","journal-title":"Biomed Res Int."},{"key":"1208_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2010.03.080","volume":"1334","author":"J Li","year":"2010","unstructured":"Li J, Zhu H, Liu Y, Li Q, Lu S, Feng M, et al. Human mesenchymal stem cell transplantation protects against cerebral ischemic injury and upregulates interleukin-10 expression in Macacafascicularis. Brain Res. 2010;1334:65\u201372. https:\/\/doi.org\/10.1016\/j.brainres.2010.03.080. Epub 20100328.","journal-title":"Brain Res."},{"issue":"3","key":"1208_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/cmi.2009.28","volume":"6","author":"N Liu","year":"2009","unstructured":"Liu N, Chen R, Du H, Wang J, Zhang Y, Wen J. Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell Mol Immunol. 2009;6(3):207\u201313. https:\/\/doi.org\/10.1038\/cmi.2009.28. PubMed PMID: 19567204; PubMed Central PMCID: PMCPMC4003064.","journal-title":"Cell Mol Immunol."},{"issue":"4","key":"1208_CR64","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3233\/RNN-130329","volume":"33","author":"SA Lowrance","year":"2015","unstructured":"Lowrance SA, Fink KD, Crane A, Matyas J, Dey ND, Matchynski JJ, et al. Bone-marrow-derived mesenchymal stem cells attenuate cognitive deficits in an endothelin-1 rat model of stroke. Restor Neurol Neurosci. 2015;33(4):579\u201388. https:\/\/doi.org\/10.3233\/RNN-130329.","journal-title":"Restor Neurol Neurosci."},{"issue":"1","key":"1208_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/scrt544","volume":"6","author":"LL Cui","year":"2015","unstructured":"Cui LL, Kerkela E, Bakreen A, Nitzsche F, Andrzejewska A, Nowakowski A, et al. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther. 2015;6(1):11. https:\/\/doi.org\/10.1186\/scrt544. Epub 20150127. PubMed PMID: 25971703; PubMed Central PMCID: PMCPMC4429328.","journal-title":"Stem Cell Res Ther."},{"issue":"6","key":"1208_CR66","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1037\/0735-7044.120.6.1285","volume":"120","author":"T Freret","year":"2006","unstructured":"Freret T, Chazalviel L, Roussel S, Bernaudin M, Schumann-Bard P, Boulouard M. Long-term functional outcome following transient middle cerebral artery occlusion in the rat: correlation between brain damage and behavioral impairment. Behav Neurosci. 2006;120(6):1285\u201398. https:\/\/doi.org\/10.1037\/0735-7044.120.6.1285.","journal-title":"Behav Neurosci."},{"issue":"10","key":"1208_CR67","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1089\/scd.2009.0011","volume":"18","author":"T Yasuhara","year":"2009","unstructured":"Yasuhara T, Matsukawa N, Hara K, Maki M, Ali MM, Yu SJ, et al. Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev. 2009;18(10):1501\u201314. https:\/\/doi.org\/10.1089\/scd.2009.0011.","journal-title":"Stem Cells Dev."},{"issue":"3","key":"1208_CR68","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1460-9568.2008.06599.x","volume":"29","author":"AU Hicks","year":"2009","unstructured":"Hicks AU, Lappalainen RS, Narkilahti S, Suuronen R, Corbett D, Sivenius J, et al. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci. 2009;29(3):562\u201374. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06599.x. Epub 20090117.","journal-title":"Eur J Neurosci."},{"issue":"1-2","key":"1208_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0022-510x(01)00557-3","volume":"189","author":"J Chen","year":"2001","unstructured":"Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci. 2001;189(1\u20132):49\u201357. https:\/\/doi.org\/10.1016\/s0022-510x(01)00557-3.","journal-title":"J Neurol Sci."},{"issue":"9","key":"1208_CR70","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/00004647-200009000-00006","volume":"20","author":"Y Li","year":"2000","unstructured":"Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu YX, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab. 2000;20(9):1311\u20139. https:\/\/doi.org\/10.1097\/00004647-200009000-00006.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"12","key":"1208_CR71","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/01.jnen.0000190068.03009.b5","volume":"64","author":"T Mimura","year":"2005","unstructured":"Mimura T, Dezawa M, Kanno H, Yamamoto I. Behavioral and histological evaluation of a focal cerebral infarction rat model transplanted with neurons induced from bone marrow stromal cells. J Neuropathol Exp Neurol. 2005;64(12):1108\u201317. https:\/\/doi.org\/10.1097\/01.jnen.0000190068.03009.b5.","journal-title":"J Neuropathol Exp Neurol."},{"key":"1208_CR72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainres.2017.12.017","volume":"1680","author":"HL Zhang","year":"2018","unstructured":"Zhang HL, Xie XF, Xiong YQ, Liu SM, Hu GZ, Cao WF, et al. Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats. Brain Res. 2018;1680:143\u201354. https:\/\/doi.org\/10.1016\/j.brainres.2017.12.017. Epub 20171221.","journal-title":"Brain Res."},{"issue":"1","key":"1208_CR73","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.jcbfm.9600311","volume":"27","author":"LH Shen","year":"2007","unstructured":"Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A, et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab. 2007;27(1):6\u201313. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600311. Epub 20060405.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"3","key":"1208_CR74","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/STROKEAHA.112.677328","volume":"44","author":"S Ishizaka","year":"2013","unstructured":"Ishizaka S, Horie N, Satoh K, Fukuda Y, Nishida N, Nagata I. Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke. 2013;44(3):720\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.112.677328. Epub 20130129.","journal-title":"Stroke"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-023-01208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-023-01208-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-023-01208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T05:48:25Z","timestamp":1744091305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-023-01208-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1007\/s12975-023-01208-7","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}